VitalWare completes financing to spur growth of revenue cycle solutions: 4 things to know

VitalWare, a provider of revenue cycle SaaS solutions to healthcare organizations, has received investment funding from F-Prime Capital Partners, formerly Fidelity Biosciences, a global venture capital firm investing in healthcare and technology.

Advertisement

Here are four things to know about the funding.

1. F-Prime Capital was the only institutional investor in the Series A financing.

2. Kerry Martin, president and CEO of VitalWare, spoke positively of the funding, saying it “helps us [the company] to continue investing in future technology, sales and marketing and talent to provide the best healthcare revenue cycle solutions available in the industry.”

3. The amount of funding was not disclosed.

4. Following the investment, F-Prime partners Jon Lim and Carl Byers have joined the VitalWare board of directors.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.